Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Narcolepsy-cataplexy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05055024
What this trial is testing

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Who this might be right for
Narcolepsy With CataplexyNarcolepsyNarcolepsy Without Cataplexy
NLS Pharmaceutics 52
Not applicableNo Longer AvailableNCT03433131
What this trial is testing

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Who this might be right for
Narcolepsy Without CataplexyNarcolepsy With Cataplexy
Harmony Biosciences Management, Inc.
Large-scale testing (Phase 3)Study completedNCT00078312
What this trial is testing

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Who this might be right for
NarcolepsySleep Apnea, ObstructiveSleep Apnea Syndromes+1 more
Cephalon 328
Large-scale testing (Phase 3)Study completedNCT03030599
What this trial is testing

The Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Who this might be right for
Narcolepsy With Cataplexy
Jazz Pharmaceuticals 201
Large-scale testing (Phase 3)Study completedNCT05059223
What this trial is testing

Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Axsome Therapeutics, Inc. 90
Large-scale testing (Phase 3)Study completedNCT01800045
What this trial is testing

Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)

Who this might be right for
Narcolepsy With CataplexyExcessive Daytime Sleepiness
Bioprojet 103
Not applicableStudy completedNCT01394614
What this trial is testing

Risk of Narcolepsy Associated With Administration of H1N1 Vaccine

Who this might be right for
Narcolepsy
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 24
Not applicableUnknownNCT03425214
What this trial is testing

Exploration of the Reward System by Functional MRI in Narco-cataplexy Patients With and Without REM Sleep Behavior Disorder

Who this might be right for
NarcolepsyCataplexy
University Hospital, Clermont-Ferrand 66
Post-approval studies (Phase 4)Study completedNCT02637076
What this trial is testing

Xyrem and Brain Dopamine in Narcolepsy

Who this might be right for
Narcolepsy With CataplexyHealthy Controls
Centre for Addiction and Mental Health 17
Testing effectiveness (Phase 2)Study completedNCT01183312
What this trial is testing

Flumazenil for the Treatment of Primary Hypersomnia

Who this might be right for
HypersomniaPrimary HypersomniaIdiopathic Hypersomnia+1 more
Lynn Marie Trotti 10
Not applicableStudy completedNCT05615584
What this trial is testing

Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence

Who this might be right for
NarcolepsyIdiopathic HypersomniaCataplexy
University Hospital, Montpellier 117
Early research (Phase 1)Study completedNCT00345800
What this trial is testing

Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes

Who this might be right for
Narcolepsy With Cataplexy
UCB Pharma SA 25
Not applicableStudy completedNCT00244465
What this trial is testing

Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription

Who this might be right for
Narcolepsy
UCB Pharma 750
Large-scale testing (Phase 3)Looking for participantsNCT07455383
What this trial is testing

Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 150
Large-scale testing (Phase 3)Study completedNCT01067222
What this trial is testing

Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy

Who this might be right for
NarcolepsyExcessive Daytime SleepinessCataplexy+1 more
Bioprojet 110
Large-scale testing (Phase 3)Study completedNCT00049803
What this trial is testing

Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients

Who this might be right for
Narcolepsy
Orphan Medical 200
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)Ended earlyNCT04096560
What this trial is testing

TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT1)Narcolepsy Type 2 (NT2)
Takeda 97
Not applicableStudy completedNCT00174174
What this trial is testing

Provigil (Modafinil) Study by Taiwan Biotech Co.

Who this might be right for
NarcolepsyCataplexySleep Disorders+2 more
National Taiwan University Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06952699
What this trial is testing

TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Who this might be right for
Narcolepsy Type 2
Takeda 88
Next Page